119 related articles for article (PubMed ID: 24288736)
41. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
42. Small-lymphocyte subpopulation rich in effector cells against Walker carcinosarcoma 256.
Kinoshita Y; Kimura S; Komano Y; Koshikawa M; Inamoto E
J Natl Cancer Inst; 1974 Sep; 53(3):867-74. PubMed ID: 4547303
[No Abstract] [Full Text] [Related]
43. Radiographic and histological evaluation of bisphosphonate alendronate and metotrexate effects on rat mandibles inoculated with Walker 256 carcinosarcoma.
Alves AP; Pessoa Cdo O; Costa-Lotufo L; Moraes Filho MO
Acta Cir Bras; 2007; 22(6):457-64. PubMed ID: 18235934
[TBL] [Abstract][Full Text] [Related]
44. Antitumor activity of 2,2-hydrazobis(3-chloro-1,4-naphthoquinone) against Walker 256(intramuscular) carcinosarcoma.
Prescott B
J Med Chem; 1972 Jan; 15(1):107. PubMed ID: 5007081
[No Abstract] [Full Text] [Related]
45. TNF signals are dispensable for the generation of CD23+ CD21/35-high CD1d-high B cells in inflamed lymph nodes.
Kuzin II; Bouta EM; Schwarz EM; Bottaro A
Cell Immunol; 2015 Aug; 296(2):133-7. PubMed ID: 25959608
[TBL] [Abstract][Full Text] [Related]
46. [Effect of plant biocomposites based on Georgian tea "per se" and in combination with cisplatin on Walker carcinosarcoma W-256 and Guerin's carcinoma growth rate in rats].
Zalietok SP; Orlovs'kyĭ OA; Hohol' SV; Samoĭlenko OA; Hulua L; Kvesitadze HI
Lik Sprava; 2006 Dec; (8):89-93. PubMed ID: 17427433
[TBL] [Abstract][Full Text] [Related]
47. Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256/DOX carcinosarcoma.
Yushko LA; Sarnatskaya VV; Sakhno LA; Hudenko NV; Paziuk LM; Maslenny VN; Melnyk VO; Nikolaev VG
Exp Oncol; 2021 Mar; 43(1):21-25. PubMed ID: 33785723
[TBL] [Abstract][Full Text] [Related]
48. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
DeWys WD; Humphreys SR; Goldin A
Cancer Chemother Rep; 1968 Feb; 52(2):229-42. PubMed ID: 5646850
[No Abstract] [Full Text] [Related]
49. [Enhancement of the antitumor effect of cyclophosphane in an experiment].
Chissov VI; Rusakov IG; Shchitkov KG; Igitov VI; Solodovnik VD
Vopr Onkol; 1985; 31(12):80-6. PubMed ID: 4082511
[TBL] [Abstract][Full Text] [Related]
50. Study of Antitumor Activity of Sodium Phenylbutyrate, Histon Deacetylase Inhibitor, on Ehrlich Carcinoma Model.
Fadeev NP; Kharisov RI; Kovan'ko EG; Pustovalov YI
Bull Exp Biol Med; 2015 Sep; 159(5):652-4. PubMed ID: 26468021
[TBL] [Abstract][Full Text] [Related]
51. [Effect of immunosuppressants on the subrenal capsule (SRC) assay as a chemosensitivity test].
Irimajiri N; Haneda J; Yokoyama E; Shirakabe M; Matsumoto M; Kusunoki T; Utsunomiya J
Gan To Kagaku Ryoho; 1988 Mar; 15(3):449-55. PubMed ID: 3348631
[TBL] [Abstract][Full Text] [Related]
52. Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine.
Sladek NE
J Pharmacol Exp Ther; 1977 Jan; 200(1):17-24. PubMed ID: 319221
[TBL] [Abstract][Full Text] [Related]
53. Studies on tumor antigens of the Walker 256 carcinosarcoma.
Meyers RL
Immunochemistry; 1975 Jul; 12(6-7):589-95. PubMed ID: 52605
[No Abstract] [Full Text] [Related]
54. Dynamics of tumor growth in Brattleboro and WAG rats injected with Walker 256 carcinosarcoma cells in different doses.
Khegay II; Popova NA; Ganilova LS; Shnyder EP; Ivanova LN
Bull Exp Biol Med; 2008 Jan; 145(1):81-3. PubMed ID: 19024010
[TBL] [Abstract][Full Text] [Related]
55. Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
Kamocka M; Kaplinska K; Mielicki WP
Clin Exp Med; 2006 Oct; 6(3):119-23. PubMed ID: 17061060
[TBL] [Abstract][Full Text] [Related]
56. Effect of cyclophosphamide and mitomycin C on Walker carcinosarcoma 256 grown in liver and muscle.
Mathur IS; Singh NB; Gupta HP; Gupta SK
Indian J Med Res; 1979 Feb; 69():284-9. PubMed ID: 429035
[No Abstract] [Full Text] [Related]
57. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
Moore DJ; Powis G; Richardson RL; Pittelkow MR
Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
[TBL] [Abstract][Full Text] [Related]
58. Lymph node metastasis and cell movement: ultrastructural studies on the rat 13762 mammary carcinoma and Walker carcinoma.
Carr I; Levy M; Orr K; Bruni J
Clin Exp Metastasis; 1985; 3(2):125-39. PubMed ID: 4042461
[TBL] [Abstract][Full Text] [Related]
59. [Effect of melatonin treatment on growth of Walker carcinosarcoma in rats].
Bostelmann W; Göcke H; Ernst B; Tessmann D
Zentralbl Allg Pathol; 1971; 114(3):289-91. PubMed ID: 4326959
[No Abstract] [Full Text] [Related]
60. Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha.
Mahatma M; Agrawal N; Dajani EZ; Nelson S; Nakamura C; Sitton J
Dig Dis Sci; 1991 Nov; 36(11):1562-8. PubMed ID: 1935494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
